{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:56:25Z","timestamp":1790873785577,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24\/01147"],"award-info":[{"award-number":["PI24\/01147"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI17\/02183"],"award-info":[{"award-number":["PI17\/02183"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00208"],"award-info":[{"award-number":["PI23\/00208"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI25\/00528"],"award-info":[{"award-number":["PI25\/00528"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.trsl.2026.09.013","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:27:36Z","timestamp":1789972056000},"page":"255-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IL-1RA administration exerts diet-dependent metabolic effects on adipose tissue function and lipid handling in male mice"],"prefix":"10.1016","volume":"297","author":[{"given":"Laura","family":"Salm\u00f3n-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Carca\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lanza-Argueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Neira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Becerril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Fr\u00fchbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-1604","authenticated-orcid":false,"given":"Javier","family":"G\u00f3mez-Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.09.013_bib0001","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7326\/ANNALS-24-02547","article-title":"Implications of the European Association for the Study of Obesity's new framework definition of obesity: prevalence and association with all-cause mortality","volume":"178","author":"Dicker","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trsl.2026.09.013_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12997","article-title":"Adipokine dysregulation and adipose tissue inflammation in human obesity","volume":"48","author":"Unamuno","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.trsl.2026.09.013_bib0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00125-003-1053-4","article-title":"Control of body weight: a physiologic and transgenic perspective","volume":"46","author":"Fr\u00fchbeck","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2026.09.013_bib0004","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.immuni.2025.09.011","article-title":"Obesity, diabetes, and inflammation: pathophysiology and clinical implications","volume":"58","author":"Donath","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.09.013_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053626","article-title":"Interleukin-1\u03b2 regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability","volume":"8","author":"Nov","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2026.09.013_bib0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41575-025-01141-0","article-title":"IL-1 family of cytokines in gastrointestinal and liver disorders","volume":"23","author":"Schw\u00e4rzler","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00125-005-0046-x","article-title":"Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents","volume":"49","author":"Somm","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2026.09.013_bib0008","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1210\/jcem.87.3.8351","article-title":"IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?","volume":"87","author":"Meier","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2026.09.013_bib0009","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2147\/JIR.S354095","article-title":"Serum levels of IL-1RA increase with obesity and type 2 diabetes in relation to adipose tissue dysfunction and are reduced after bariatric surgery in parallel to adiposity","volume":"15","author":"Fr\u00fchbeck","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.trsl.2026.09.013_bib0010","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.09.013_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107265","article-title":"IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis","volume":"9","author":"Negrin","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2026.09.013_bib0012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12933-014-0158-z","article-title":"The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats","volume":"13","author":"Vallejo","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098398","article-title":"Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice","volume":"9","author":"Lancha","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2026.09.013_bib0014","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jnutbio.2009.05.004","article-title":"Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans","volume":"21","author":"G\u00f3mez-Ambrosi","year":"2010","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.trsl.2026.09.013_bib0015","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1038\/s41598-017-02848-0","article-title":"Normalization of adiponectin concentrations by leptin replacement in ob\/ob mice is accompanied by reductions in systemic oxidative stress and inflammation","volume":"7","author":"Fr\u00fchbeck","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2026.09.013_bib0016","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1096\/fj.00-0829hyp","article-title":"Rationale for the existence of additional adipostatic hormones","volume":"15","author":"Fr\u00fchbeck","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2026.09.013_bib0017","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0018","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/21623945.2017.1402151","article-title":"Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk","volume":"7","author":"Fr\u00fchbeck","year":"2018","journal-title":"Adipocyte"},{"key":"10.1016\/j.trsl.2026.09.013_bib0019","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/nu11020454","article-title":"Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation","volume":"11","author":"Fr\u00fchbeck","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.trsl.2026.09.013_bib0020","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","article-title":"The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state","volume":"15","author":"Hodson","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0021","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1007\/s00125-014-3347-0","article-title":"Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss","volume":"57","author":"Dharuri","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2026.09.013_bib0022","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmet.2017.10.008","article-title":"Brown fat AKT2 is a cold-induced kinase that stimulates ChREBP-mediated de novo lipogenesis to optimize fuel storage and thermogenesis","volume":"27","author":"Sanchez-Gurmaches","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2026.09.013_bib0023","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00109-009-0486-8","article-title":"Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and -9 activity in humans","volume":"87","author":"Catal\u00e1n","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.trsl.2026.09.013_bib0024","first-page":"1515","article-title":"Role of extracellular matrix remodelling in adipose tissue pathophysiology. Relevance in the development of obesity","volume":"27","author":"Catal\u00e1n","year":"2012","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cmet.2013.06.016","article-title":"Fibrosis and adipose tissue dysfunction","volume":"18","author":"Sun","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2026.09.013_bib0026","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-physiol-060721-092930","article-title":"Adipose tissue fibrosis in obesity: etiology and challenges","volume":"84","author":"Marcelin","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0027","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.28456","article-title":"Interleukin-1 and inflammasomes in alcoholic liver disease\/acute alcoholic hepatitis and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"64","author":"Tilg","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2026.09.013_bib0028","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/CIRCULATIONAHA.107.740233","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction","volume":"117","author":"Abbate","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2026.09.013_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.040474","article-title":"Protective effects of interleukin-1 inhibition with anakinra in mouse models of ischemic stroke with and without reperfusion","volume":"14","author":"Chaparro-Cabanillas","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trsl.2026.09.013_bib0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-8587(15)00034-0","article-title":"Interleukin 1 Genetics Consortium. Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a mendelian randomisation analysis","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0031","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc09-0533","article-title":"Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes","volume":"32","author":"Larsen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2026.09.013_bib0032","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1684\/ecn.2009.0152","article-title":"IL-1 receptor antagonism and muscle gene expression in patients with type 2 diabetes","volume":"20","author":"Berchtold","year":"2009","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.trsl.2026.09.013_bib0033","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/jc.2010-2992","article-title":"Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study","volume":"96","author":"van Asseldonk","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2026.09.013_bib0034","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2015.06.003","article-title":"One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus","volume":"160","author":"van Asseldonk","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0035","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(13)60023-9","article-title":"Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials","volume":"381","author":"Moran","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2026.09.013_bib0036","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","article-title":"Inhibition of interleukin-1\u03b2 and reduction in atherothrombotic cardiovascular events in the CANTOS trial","volume":"76","author":"Everett","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2026.09.013_bib0037","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of interleukin-1\u03b2 inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2026.09.013_bib0038","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2016.07.768","article-title":"Arterial effects of canakinumab in patients with atherosclerosis and type 2 diabetes or glucose intolerance","volume":"68","author":"Choudhury","year":"2016","journal-title":"J Am Coll Cardiol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:59:12Z","timestamp":1790870352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S1931524426001982"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.09.013","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-1RA administration exerts diet-dependent metabolic effects on adipose tissue function and lipid handling in male mice","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}